Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Scrip Team
Executives On The Move: New CEOs Vaxil Bio and Akero Therapeutics, with Some Big Pharma Execs Joining Smaller Companies
This week’s appointments include a new chief business officer at Sutro Biopharma and a new chief medical officer at Crescendo Biologics. In addition, management from AstraZeneca and Gilead Biosciences take on the CEO role at smaller firms.
We report this week company promotions: at Teva Pharmaceutical Industries a new president of API and Biologics Operations, and at Aileron Therapeutics a new President and CEO. Also, we announce in new hires a chief commercial officer at Halozyme Therapeutics and a CEO at Rheos Medicines.
Executives On The Move: Management Changes at Bristol-Myers Squibb Company, Merck KGaA And Eli Lilly
This week’s appointments include a new chief commercial officer at Bristol-Myers Squibb, a global head of innovation medicine at Merck KGaA, and president at Lilly Oncology.
Executives On The Move: New Hires at Achillion And Bayer, And Promotions At Allegro Ophthalmics And Merz Pharma
This week’s new appointments include C-level promotions at Allegro Ophthalmics, Merz Pharma and Athenex. In addition, new directors joined the boards of Dicerna Pharmaceuticals and Spring Bank Pharmaceuticals.
Scrip’s new-look appointments feature brings you details of new hires and promotions within the pharma and biotech world from the past week. It includes a new CEO at i2 Pharmaceuticals and other senior appointments at Achillion Pharmaceuticals, Hikma Pharmaceuticals USA and Portola Pharmaceuticals. Click on the table heading tabs to see details of the industry’s latest company moves and promotions.
Appointments: Senior Hires At Allergan, Novartis, Array Biopharma, Zelluna Immunotherapy, Grail, Alzheon And Sigilon Therapeutics
Pfizer Oncology has lost its CMO to Allergan, while Novartis beefs up its ethical leadership, Array Biopharma appoints a new chair and Sigilon raids Bioverativ for its new CEO.